FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Blake Gilks

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
C Blake Gilks; Dianne Miller
Opportunistic salpingectomy for women at low risk for development of ovarian carcinoma: The time has come.
C Blake Gilks; Esther Oliva; Robert A Soslow
Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma.
Caroline H Diep; C Blake Gilks; Steve E Kalloger; Peter A Argenta; Nathan J Charles; Carol A Lange
Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Blake Gilks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: C Blake Gilks; Dianne Miller
Opportunistic salpingectomy for women at low risk for development of ovarian carcinoma: The time has come.
Gynecologic oncology 2013;129(3):443-4.
2013: C Blake Gilks; Esther Oliva; Robert A Soslow
Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma.
The American journal of surgical pathology 2013;37(6):874-81.
2013: Caroline H Diep; C Blake Gilks; Steve E Kalloger; Peter A Argenta; Nathan J Charles; Carol A Lange
Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.
Cell cycle (Georgetown, Tex.) 2013;12(9):1433-49.
2013: Anna Isphording; Nataliya Nelnyk; Torsten O Nielsen; Marisa R Nucci; Rola H Ali; C Blake Gilks; Angela Goytain; Lien N Hoang; David G Huntsman; Julie Irving; Cheng-Han Lee
YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
Human pathology 2013;44(5):837-43.
2013: Ananta Gurung; Tawny Hung; Jason Morin; C Blake Gilks
Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.
Histopathology 2013;62(1):59-70.
2013: Janice S Kwon; Jessica N McAlpine; Mary McCullum; Gary Pansegrau; Anna Tinker; Melissa Housty; C Blake Gilks
Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
Obstetrics and gynecology 2013;121(1):14-24.
2013: James P Beirne; C Blake Gilks; Ian J G Harley; Steve E Kalloger; Perry Maxwell; Jessica McAlpine; Jennifer E Quinn; W Glenn McCluggage
BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2013;23(1):113-8.
2013: Michael S Anglesio; Jamie Bakkum-Gamez; David D Bowtell; Blaise Clarke; Sambasivarao Damaraju; Sian Fereday; Sarah Ferguson; Laura Galletta; Joaquin J Garcia; C Blake Gilks; David Huntsman; Steve E Kalloger; Stefan Kommoss; Henry Porter; John K Schoolmeester; Janine Senz; Patricia Shaw; Helen Steed; Attila Teoman; Anna V Tinker; Mary C Tolcher; Boris J Winterhoff; Winnie Yang; Ghassan Allo; Jessica N McAlpine
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas.
The Journal of pathology 2013;229(1):111-20.
2012: Alicia Tone; Sarah Finlayson; C Blake Gilks; Mark Heywood; David Huntsman; Jessica N McAlpine; Dianne Miller
It sounded like a good idea at the time.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC 2012;34(12):1127-32.
2012: Fang-I Lu; Anna-Marie Mulligan; Aaron Pollett; Paul Ryan; Particia A Shaw; Keiyan Sy; Ghassan Allo; C Blake Gilks; Blaise A Clarke
Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2012;31(6):524-31.
2012: Rola H Ali; Steve Kalloger; Margaret Luk; Jeffrey D Seidman; C Blake Gilks
Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2012;31(6):499-506.
2012: Melissa K McConechy; Helen McDonald; David G Mutch; Leah M Prentice; Amy P Schmidt; Janine Senz; Sohrab P Shah; Alicia A Tone; Kane Tse; Kimberly C Wiegand; Winnie Yang; Thomas Zeng; Maggie C U Cheang; Jiarui Ding; C Blake Gilks; Paul J Goodfellow; Martin Hirst; Cheng-Han Lee; Jessica N McAlpine; David Huntsman
Use of mutation profiles to refine the classification of endometrial carcinomas.
The Journal of pathology 2012;228(1):20-30.
2012: Kasmintan A Schrader; Sean Young; C Blake Gilks; Samantha Hansford; David G Huntsman; Jane Hurlburt; Steve E Kalloger; Jessica N McAlpine
Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Obstetrics and gynecology 2012;120(2 Pt 1):235-40.
2012: Hajime Oishi; Tomohiro Osugi; Kazuyoshi Tsutsui; Tetsu Yano; George E Bentley; C Blake Gilks; Christian Klausen; Peter C K Leung
The human gonadotropin-inhibitory hormone ortholog RFamide-related peptide-3 suppresses gonadotropin-induced progesterone production in human granulosa cells.
Endocrinology 2012;153(7):3435-45.
2012: Alicia A Tone; Dianne M Miller; Judith Pike; Shannon Salvador; Gavin C E Stuart; Kenneth D Swenerton; Anna V Tinker; Mark S Carey; Trevor Cohen; Tom Ehlen; Sarah J Finlayson; C Blake Gilks; Mark Heywood; Paul J Hoskins; David G Huntsman; Janice S Kwon; Cheng-Han Lee; Marette Lee; Jessica N McAlpine
The role of the fallopian tube in ovarian cancer.
Clinical advances in hematology & oncology : H&O 2012;10(5):296-306.
2012: Cheng-Han Lee; Adrian Mariño-Enriquez; Rola H Ali; Frédéric Amant; Sarah Chiang; Paola Dal Cin; Maria Debiec-Rychter; Jonathan A Fletcher; C Blake Gilks; Esther Oliva; Wenbin Ou; Matt van de Rijn; Meijun Zhu; Marisa R Nucci
The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
The American journal of surgical pathology 2012;36(5):641-53.
2012: Jessica N McAlpine; Katy Milne; Brad H Nelson; Henry Porter; Leah M Prentice; Janine Senz; Sohrab P Shah; Jiarui Ding; David G Huntsman; Steve Kalloger; Martin Köbel; C Blake Gilks
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(5):740-50.
2012: Jane A Cipollone; C Blake Gilks; Marcia L Graves; Steve Kalloger; Martin Köbel; Kelly M McNagny; Tak Poon; Calvin D Roskelley
The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma.
Clinical & experimental metastasis 2012;29(3):239-52.
2012: W Glenn McCluggage; Lynette E Connolly; Steve Kalloger; Hilary A McBride; C Blake Gilks
HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis.
Histopathology 2012;60(4):547-53.
2012: Paul Ryan; Kara Semotiuk; Melyssa Aronson; Bharati Bapat; Sarah E Ferguson; Steven Gallinger; C Blake Gilks; Spring Holter; Steve Kalloger; Janice Kwon; Anna Marie Mulligan; Aaron Pollett; Blaise A Clarke
Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
Cancer 2012;118(3):681-8.
2012: Cheng-Han Lee; Adrian Mariño-Enriquez; Marco A Marra; Mark Mayeda; Jessica N McAlpine; Andrew McPherson; Marisa R Nucci; Wen-Bin Ou; Leah M Prentice; Sohrab P Shah; Matt van de Rijn; Yuexiang Wang; Robert B West; Michael B Yaffe; Meijun Zhu; Frederic Amant; Alayne L Brunner; Paola Dal Cin; Maria Debiec-Rychter; Christopher A French; C Blake Gilks; Xiangqian Guo; David G Huntsman; Steven J M Jones; Jonathan A Fletcher
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(3):929-34.
2012: Katy Milne; Winnie Sun; John Webb; Cheryl Alexander; Blaise Clarke; Kristy Dillon; C Blake Gilks; Steve Kalloger; Martin Köbel; Brad H Nelson
Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes.
Journal of translational medicine 2012;10():33.
2011: W Glenn McCluggage; Robert A Soslow; C Blake Gilks
Patterns of p53 immunoreactivity in endometrial carcinomas: 'all or nothing' staining is of importance.
Histopathology 2011;59(4):786-8.
2011: Iñigo Espinosa; C Blake Gilks; Cheng-Han Lee; Rui Li; Robert J Marinelli; Kelli D Montgomery; Torsten Nielsen; Andrew H Beck; Hong Wei Cheng; Badreddin Edris; Sushama Varma; Yuzhuo Wang; Robert B West; Matt van de Rijn
CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.
The American journal of pathology 2011;179(4):2100-7.
2011: C Blake Gilks; Guangming Han; Martin Köbel; Teri Longacre; W Glenn McCluggage; Jeff D Seidman; Patricia Shaw; Blaise A Clarke; Robert A Soslow
Letter to the editor regarding 'Roh MH, Lassin Y, Miron A et al. High-grade fimbrial-ovarian carcinomas are unified by p53, PTEN and PAX2 expression'.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(9):1281-2; author reply 1282-3.
2011: Sarah Chiang; C Blake Gilks; David Huntsman; Cheng-Han Lee; Jessica N McAlpine; Nataliya Melnyk; Rola Ali; Esther Oliva
Frequency of known gene rearrangements in endometrial stromal tumors.
The American journal of surgical pathology 2011;35(9):1364-72.
2011: David G Huntsman; C Blake Gilks
Surgical staging of early stage epithelial ovarian cancer.
Gynecologic oncology 2011;122(2):460-1; author reply 461-2.
2011: Andrea Facciabene; C Blake Gilks; Phyllis A Gimotty; Ian S Hagemann; Priti Lal; Xiaohui Peng; Li-Ping Wang; Lin Zhang; Klara Balint; Andrea Barchetti; George Coukos
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.
Nature 2011;475(7355):226-30.
2011: Nikita Makretsov; Joel Mercer; Dragana Palavdzic; Louise Quenneville; Emina E Torlakovic; Reza Alaghehbandan; John Garratt; C Blake Gilks
Development of an evidence-based approach to external quality assurance for breast cancer hormone receptor immunohistochemistry: comparison of reference values.
Archives of pathology & laboratory medicine 2011;135(7):874-81.
2011: Martin Köbel; Dmitry Turbin; Dongxia Gao; David Huntsman; Steve Kalloger; C Blake Gilks
Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sites.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2011;30(4):366-71.
2011: Abdulmohsen Alhejaily; Tara Baetz; Julia Brettschneider; Andrew G Day; Patricia L Farmer; Harriet E Feilotter; Cheryl J Foster; C Blake Gilks; Brianne Wood; David P LeBrun
Differential expression of cell-cycle regulatory proteins defines distinct classes of follicular lymphoma.
Human pathology 2011;42(7):972-82.
2011: Janice S Kwon; Jenna L Scott; C Blake Gilks; Molly S Daniels; Charlotte C Sun; Karen H Lu
Testing women with endometrial cancer to detect Lynch syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(16):2247-52.
2011: Emanuela D'Angelo; Inigo Espinosa; Rola Ali; C Blake Gilks; Matt van de Rijn; Cheng-Han Lee; Jaime Prat
Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis.
Gynecologic oncology 2011;121(2):328-33.
2011: Michael S Anglesio; Joshy George; Hagen Kulbe; Michael Friedlander; Danny Rischin; Charlotte Lemech; Jeremy Power; Jermaine Coward; Prue A Cowin; Colin M House; Probir Chakravarty; Kylie L Gorringe; Ian G Campbell; Aikou Okamoto; Michael J Birrer; David G Huntsman; Anna de Fazio; Steve Kalloger; Frances Balkwill; C Blake Gilks; David D L Bowtell
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(8):2538-48.
2011: Melissa K McConechy; Michael S Anglesio; Steve Kalloger; Winnie Yang; Janine Senz; Christine Chow; Alireza Heravi Moussavi; Gregg B Morin; Anne-Marie Mes-Masson; Mark S Carey; Jessica N McAlpine; Janice S Kwon; Leah M Prentice; Niki Boyd; Sohrab P Shah; C Blake Gilks; David Huntsman
Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
The Journal of pathology 2011;223(5):567-73.
2011: Osama M Al-Agha; Hassan F Huwait; Christine Chow; Winnie Yang; Janine Senz; Steve Kalloger; David Huntsman; Robert H Young; C Blake Gilks
FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
The American journal of surgical pathology 2011;35(4):484-94.
2011: Steve Kalloger; Martin Köbel; Samuel Leung; Erika Mehl; Dongxia Gao; Krista M Marcon; Christine Chow; Blaise A Clarke; David Huntsman; C Blake Gilks
Calculator for ovarian carcinoma subtype prediction.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(4):512-21.
2011: J N McAlpine; S El Hallani; S F Lam; Steve Kalloger; M Luk; David Huntsman; Calum MacAulay; C Blake Gilks; Dianne M Miller; P M Lane
Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection.
Gynecologic oncology 2011;120(3):385-92.
2011: Ursula Kortmann; Jessica N McAlpine; Hui Xue; Jun Guan; Gavin Ha; Sophie Tully; Sharaz Shafait; Alan Lau; Aaron N Cranston; Mark J O'Connor; David Huntsman; Yuzhuo Wang; C Blake Gilks
Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(4):783-91.
2011: Takayo Ota; Amy C Clayton; Douglas M Minot; Viji Shridhar; Lynn C Hartmann; C Blake Gilks; Jeremy R Chien
Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(2):277-87.
2011: Michael P Stany; Rebecca L Stone; Vinod Vathipadiekal; Pablo Vivas-Mejia; Yuwei Wang; Yu-Zhuo Wang; Hui Xue; David Bowtell; Susan L Ellard; C Blake Gilks; Peter W Gout; David G Huntsman; Takashi Kagami; Gabriel Lopez-Berestein; Jessica N McAlpine; Dianne M Miller; Samuel C Mok; Laurent Ozbun; Anil K Sood; Michael J Birrer
Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.
PloS one 2011;6(7):e21121.
2011: Kristin L M Boylan; Benjamin Misemer; Melissa S Derycke; John D Andersen; Katherine M Harrington; Steve Kalloger; C Blake Gilks; Stefan E Pambuccian; Amy P N Skubitz
Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation.
International journal of molecular sciences 2011;12(2):1334-58.
2011: Deborah DeLair; Esther Oliva; Martin Köbel; Antonio Macias; C Blake Gilks; Robert A Soslow
Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.
The American journal of surgical pathology 2011;35(1):36-44.
2010: Tawny Hung; Robert Wolber; John Garratt; Steven Kalloger; C Blake Gilks
Improved breast cancer biomarker detection through a simple, high frequency, low cost external proficiency testing program.
Pathology 2010;42(7):637-42.
2010: Melissa S Derycke; Stefan E Pambuccian; C Blake Gilks; Steve Kalloger; Abderrezak Ghidouche; Marc Lopez; Robin L Bliss; Melissa A Geller; Peter A Argenta; Katherine M Harrington; Amy P N Skubitz
Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker.
American journal of clinical pathology 2010;134(5):835-45.
2010: Martin Köbel; Alexander Reuss; Andreas du Bois; Stefan Kommoss; Friedrich Kommoss; Dongxia Gao; Steve Kalloger; David Huntsman; C Blake Gilks
The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.
The Journal of pathology 2010;222(2):191-8.
2010: Jefferson Terry; Emina Torlakovic; Martin Trotter; John Garratt; Penny Barnes; Allen Gown; Norman Pettigrew; C Blake Gilks
Canadian external quality assurance program for breast cancer biomarkers.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2010;18(5):486.
2010: Sara E Meyer; Jason R Hasenstein; Avinash Baktula; Chinavenmani S Velu; Yan Xu; Huajing Wan; Jeffrey A Whitsett; C Blake Gilks; H Leighton Grimes
Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival.
The American journal of pathology 2010;177(3):1503-13.
2010: Anna Marie Mulligan; Anna Plotkin; Marjan Rouzbahman; Robert A Soslow; C Blake Gilks; Blaise Alexander Clarke
Endometrial giant cell carcinoma: a case series and review of the spectrum of endometrial neoplasms containing giant cells.
The American journal of surgical pathology 2010;34(8):1132-8.
2010: Abdulmohsen Alkushi; Martin Köbel; Steve Kalloger; C Blake Gilks
High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2010;29(4):343-50.
2010: Martin Köbel; Steve Kalloger; Patricia M Baker; Carol A Ewanowich; Jocelyne Arseneau; Viktor Zherebitskiy; Soran Abdulkarim; Samuel Leung; Máire A Duggan; Dan Fontaine; Robin Parker; David G Huntsman; C Blake Gilks
Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study.
The American journal of surgical pathology 2010;34(7):984-93.
2010: C Blake Gilks; David Huntsman
Diagnostic uncertainty in the interpretation of small atypical acinar lesions of prostate.
The American journal of surgical pathology 2010;34(7):1071; author reply 1072.
2010: Blaise A Clarke; C Blake Gilks
Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.
Journal of clinical pathology 2010;63(5):410-5.
2010: Ali Dastranj Tabrizi; Steve Kalloger; Martin Köbel; Jane Cipollone; Calvin D Roskelley; Erika Mehl; C Blake Gilks
Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2010;29(2):99-107.
2010: Manohar Pradhan; Björn A Risberg; Claes G Tropé; Matt van de Rijn; C Blake Gilks; Cheng-Han Lee
Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation.
BMC cancer 2010;10():493.
2010: C Blake Gilks
Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.
Journal of oncology 2010;2010():740968.
2010: Martin Köbel; Steve Kalloger; Jennifer L Santos; David Huntsman; C Blake Gilks; kenneth d swenerton
Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.
Gynecologic oncology 2010;116(1):50-6.
2009: Martin Köbel; C Blake Gilks; David G Huntsman
Adult-type granulosa cell tumors and FOXL2 mutation.
Cancer research 2009;69(24):9160-2.
2009: Cheng-Han Lee; Dmitry A Turbin; Y-C Vanessa Sung; Inigo Espinosa; Kelli Montgomery; Matt van de Rijn; C Blake Gilks
A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(12):1519-31.
2009: Kristin C Jensen; Torsten O Nielsen; C Blake Gilks; Robert B West
HER2 Intermediate Breast Cancers.
The American journal of surgical pathology 2009;33(11):1739; author reply 1739-40.
2009: Jefferson Terry; Emina Emilia Torlakovic; John Garratt; Denise Miller; Martin Köbel; Jesse Cooper; Shakir Bahzad; Dragana Pilavdzic; Frances O'Malley; Anne E O'Brien; Sandip SenGupta; Edward Alport; Bernard Têtu; Bryan Knight; Norman M Pettigrew; Richard Berendt; Robert Wolber; Martin J Trotter; Robert H Riddell; Louis Gaboury; Ford Elms; anthony magliocco; Penny Barnes; Allen M Gown; C Blake Gilks
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2009;17(5):375-82.
2009: C Blake Gilks; Jaime Prat
Ovarian carcinoma pathology and genetics: recent advances.
Human pathology 2009;40(9):1213-23.
2009: Inigo Espinosa; Andrew H Beck; Cheng-Han Lee; Shirley Zhu; Kelli D Montgomery; Robert J Marinelli; Kristen N Ganjoo; Torsten O Nielsen; C Blake Gilks; Robert B West; Matt van de Rijn
Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
The American journal of pathology 2009;174(6):2347-56.
2009: Martin Köbel; C Blake Gilks; David G Huntsman
Dicer and Drosha in ovarian cancer.
The New England journal of medicine 2009;360(11):1150-1; author reply 1151.
2009: Martin Köbel; Haodong Xu; Patricia A Bourne; Betsy O Spaulding; Ie-Ming Shih; Tsui-Lien Mao; Robert A Soslow; Carol A Ewanowich; Steve Kalloger; Erika Mehl; Cheng-Han Lee; David Huntsman; C Blake Gilks
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(3):469-75.
2009: Blaise Clarke; Anna V Tinker; Cheng-Han Lee; Subbaya Subramanian; Matt van de Rijn; Dmitry Turbin; Steve Kalloger; Guangming Han; Kathy Ceballos; Mark G Cadungog; David Huntsman; George Coukos; C Blake Gilks
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(3):393-402.
2009: Jessica N McAlpine; Kimberly C Wiegand; Russell Vang; Brigitte M Ronnett; Anna Adamiak; Martin Köbel; Steve Kalloger; kenneth d swenerton; David Huntsman; C Blake Gilks; Dianne M Miller
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.
BMC cancer 2009;9():433.
2009: Kasmintan A Schrader; Bella Gorbatcheva; Janine Senz; Alireza Heravi Moussavi; Nataliya Melnyk; Clara Salamanca; Sarah Maines-Bandiera; Susanna L Cooke; Peter Leung; James D Brenton; C Blake Gilks; John Monahan; David Huntsman
The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.
PloS one 2009;4(11):e7988.
2009: Cheng-Han Lee; Subbaya Subramanian; Andrew H Beck; Inigo Espinosa; Janine Senz; Shirley X Zhu; David Huntsman; Matt van de Rijn; C Blake Gilks
MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.
PloS one 2009;4(10):e7314.
2009: Katy Milne; Martin Köbel; Steve Kalloger; Rebecca O Barnes; Dongxia Gao; C Blake Gilks; Peter H Watson; Brad H Nelson
Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.
PloS one 2009;4(7):e6412.
2009: Martin Köbel; Steve Kalloger; Jon Carrick; David Huntsman; Haider Asad; Esther Oliva; Carol A Ewanowich; Robert A Soslow; C Blake Gilks
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
The American journal of surgical pathology 2009;33(1):14-21.
2008: Martin Köbel; Steve Kalloger; Niki Boyd; Steven McKinney; Erika Mehl; Chana Palmer; Samuel Leung; Nathan Bowen; Diana N Ionescu; Ashish Rajput; Leah M Prentice; Dianne Miller; Jennifer Santos; Kenneth Swenerton; C Blake Gilks; David Huntsman
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
PLoS medicine 2008;5(12):e232.
2008: Kristin C Jensen; David F Schaeffer; Maggie Cheang; Kelli Montgomery; Robert B West; C Blake Gilks; Doug Ross; Gulisa Turashvili; Stuart Schnitt; Matt van de Rijn
Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(12):1413-20.
2008: Brigitte M Ronnett; Anna V Yemelyanova; Russell Vang; C Blake Gilks; Dianne Miller; Patti Gravitt; Robert J Kurman
Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
The American journal of surgical pathology 2008;32(12):1835-53.
2008: M M M Woo; Clara M Salamanca; M Miller; Jaime Symowicz; P C K Leung; C Oliveira; Thomas G Ehlen; C Blake Gilks; David Huntsman; Nelly Auersperg
Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(6):1234-47.
2008: Michelle P Wong; Mary Cheang; Erika Yorida; Andrew J Coldman; C Blake Gilks; David Huntsman; Ken Berean
Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients.
Pathology 2008;40(6):611-6.
2008: Michelle M M Woo; Clara M Salamanca; Jaime Symowicz; M Sharon Stack; Dianne M Miller; Peter C Leung; C Blake Gilks; Nelly Auersperg
SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells.
Gynecologic oncology 2008;111(1):125-31.
2008: Nelly Auersperg; Michelle M M Woo; C Blake Gilks
The origin of ovarian carcinomas: a developmental view.
Gynecologic oncology 2008;110(3):452-4.
2008: C Blake Gilks; Diana N Ionescu; Steve Kalloger; Martin Köbel; Julie Irving; Blaise Clarke; Jennifer Santos; Nhu Le; Veronika Moravan; Kenneth Swenerton
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
Human pathology 2008;39(8):1239-51.
2008: Joshua Z Press; Jennifer A Kenyon; Hui Xue; Melinda A Miller; Alessandro De Luca; Dianne M Miller; David Huntsman; C Blake Gilks; Jessica N McAlpine; Yu-Zhuo Wang
Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy.
Gynecologic oncology 2008;110(2):256-64.
2008: Dmitry A Turbin; Samuel Leung; Mary Cheang; Hagen A Kennecke; Kelli D Montgomery; Steven McKinney; Diana O Treaba; Niki Boyd; Lynn C Goldstein; Sunil Badve; Allen M Gown; Matt van de Rijn; Torsten O Nielsen; C Blake Gilks; David Huntsman
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
Breast cancer research and treatment 2008;110(3):417-26.
2008: Guangming Han; C Blake Gilks; Samuel Leung; Carol A Ewanowich; Julie A Irving; Teri A Longacre; Robert A Soslow
Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
The American journal of surgical pathology 2008;32(7):955-64.
2008: Andrew H Beck; Inigo Espinosa; C Blake Gilks; Matt van de Rijn; Robert B West
The fibromatosis signature defines a robust stromal response in breast carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2008;88(6):591-601.
2008: Lindsay A Brown; Steve Kalloger; Melinda A Miller; Ie-Ming Shih; Steven E McKinney; Jennifer L Santos; Ken Swenerton; Paul Spellman; Joe Gray; C Blake Gilks; David Huntsman
Amplification of 11q13 in ovarian carcinoma.
Genes, chromosomes & cancer 2008;47(6):481-9.
2008: Cheng-Han Lee; Inigo Espinosa; Suzan Vrijaldenhoven; Subbaya Subramanian; Kelli D Montgomery; Shirley Zhu; Robert J Marinelli; Johannes L Peterse; Neal Poulin; Torsten O Nielsen; Robert B West; C Blake Gilks; Matt van de Rijn
Prognostic significance of macrophage infiltration in leiomyosarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1423-30.
2008: Katy Milne; Rebecca O Barnes; Adam Girardin; Melanie A Mawer; Nancy J Nesslinger; Alvin Ng; Julie S Nielsen; Robert Sahota; Eric Tran; John Webb; May Q Wong; Darin A Wick; Andrew Wray; Elissa McMurtrie; Martin Köbel; Steve Kalloger; C Blake Gilks; Peter H Watson; Brad H Nelson
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.
PloS one 2008;3(10):e3409.
2008: Martin Köbel; David Huntsman; C Blake Gilks
Critical molecular abnormalities in high-grade serous carcinoma of the ovary.
Expert reviews in molecular medicine 2008;10():e22.
2008: Joshua Z Press; Alessandro De Luca; Niki Boyd; Sean Young; Armelle Troussard; Yolanda Ridge; Pardeep Kaurah; Steve Kalloger; Katherine A Blood; Margaret Smith; Paul Spellman; Yuker Wang; Dianne M Miller; Douglas E Horsman; Malek Faham; C Blake Gilks; Joe Gray; David Huntsman
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.
BMC cancer 2008;8():17.
2008: Ashish B Rajput; Dmitry Turbin; Mary Cheang; David K Voduc; Sam Leung; Karen Gelmon; C Blake Gilks; David Huntsman
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.
Breast cancer research and treatment 2008;107(2):249-57.
2007: Abdulmohsen Alkushi; Blaise A Clarke; Majid Akbari; Nikita Makretsov; Peter Lim; Dianne Miller; anthony magliocco; Andrew J Coldman; Matt van de Rijn; David Huntsman; Robin Parker; C Blake Gilks
Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(11):1156-65.
2007: Takayo Ota; C Blake Gilks; Teri A Longacre; Peter C K Leung; Nelly Auersperg
HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
Reproductive sciences (Thousand Oaks, Calif.) 2007;14(6):605-14.
2007: John S Cupp; Melinda A Miller; Kelli D Montgomery; Torsten O Nielsen; John X O'Connell; David Huntsman; Matt van de Rijn; C Blake Gilks; Robert B West
Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
The American journal of surgical pathology 2007;31(6):970-6.
2007: Leah M Prentice; Christian Klausen; Steve Kalloger; Martin Köbel; Steven McKinney; Jennifer L Santos; Challayne Kenney; Erika Mehl; C Blake Gilks; Peter Leung; Ken Swenerton; David Huntsman; Samuel A J Aparicio
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma.
BMC medicine 2007;5():33.
2007: Nikita Makretsov; Malcolm Hayes; Beverley A Carter; Shahriar Dabiri; C Blake Gilks; David Huntsman
Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(1):84-9.
2006: Mary Cheang; Diana Treaba; Caroline H Speers; Ivo A Olivotto; Chris D Bajdik; Stephen K Chia; Lynn C Goldstein; Karen Gelmon; David Huntsman; C Blake Gilks; Torsten O Nielsen; Allen M Gown
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5637-44.
2006: David Hayes; Stefano Monti; Giovanni Parmigiani; C Blake Gilks; Katsuhiko Naoki; Arindam Bhattacharjee; Mark A Socinski; Charles M Perou; Matthew Meyerson
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):5079-90.
2006: H Masoudi; Dirk Van Niekerk; C Blake Gilks; M Cheang; Karl Bilek; U Fischer; Thomas G Ehlen; D Miller; Lars-Christian Horn
Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker.
Histopathology 2006;49(5):542-5.
2006: Jung-Hye Choi; C Blake Gilks; Nelly Auersperg; Peter C K Leung
Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary.
The Journal of clinical endocrinology and metabolism 2006;91(11):4562-70.
2006: Joyce Wu; Cathy Lee; Daniel Yokom; Helen Jiang; Mary Cheang; Erika Yorida; Dmitry Turbin; Isabelle M Berquin; Peter R Mertens; Thomas Iftner; C Blake Gilks; Sandra E Dunn
Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.
Cancer research 2006;66(9):4872-9.
2006: Takayo Ota; Kyung Bok Choi; C Blake Gilks; Peter C K Leung; Nelly Auersperg
Cell type- and stage-specific changes in HOXA7 protein expression in human ovarian folliculogenesis: possible role of GDF-9.
Differentiation; research in biological diversity 2006;74(1):1-10.
2006: Robert B West; Brian P Rubin; Melinda A Miller; Subbaya Subramanian; Gulsah Kaygusuz; Kelli Montgomery; Shirley Zhu; Robert J Marinelli; Alessandro De Luca; Erinn Downs-Kelly; John R Goldblum; Christopher L Corless; Patrick O Brown; C Blake Gilks; Torsten O Nielsen; David Huntsman; Matt van de Rijn
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(3):690-5.
2006: Dmitry Turbin; Mary Cheang; Chris D Bajdik; Karen Gelmon; Erika Yorida; Alessandro De Luca; Torsten O Nielsen; David Huntsman; C Blake Gilks
MDM2 protein expression is a negative prognostic marker in breast carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(1):69-74.
2005: Leah M Prentice; Ashleen Shadeo; Valia Lestou; Melinda A Miller; Ronald deLeeuw; Nikita Makretsov; Dmitry Turbin; Lindsay A Brown; Nicol Macpherson; Erika Yorida; Mary Cheang; John Bentley; Stephen Chia; Torsten O Nielsen; C Blake Gilks; Wan Lam; David Huntsman
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
Oncogene 2005;24(49):7281-9.
2005: Yuwei Wang; Hui Xue; Jean-Claude Cutz; Jane Bayani; Nasrin R Mawji; Wilfred G Chen; Lester J Goetz; Simon W Hayward; Marianne D Sadar; C Blake Gilks; Peter W Gout; Jeremy A Squire; Gerald R Cunha; Yu-Zhuo Wang
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.
Laboratory investigation; a journal of technical methods and pathology 2005;85(11):1392-404.
2005: Catherine Ludwick; C Blake Gilks; Dianne Miller; Hadi Yaziji; Philip B Clement
Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2005;24(3):205-17.
2005: Cheng-Han Lee; David Huntsman; Mary Cheang; Robin L Parker; Lindsay Brown; Paul Hoskins; Dianne Miller; C Blake Gilks
Assessment of Her-1, Her-2, And Her-3 expression and Her-2 amplification in advanced stage ovarian carcinoma.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2005;24(2):147-52.
2005: Abdulmohsen Alkushi; Zainab H Abdul-Rahman; Peter Lim; Michael Schulzer; Andrew J Coldman; Steve Kalloger; Dianne Miller; C Blake Gilks
Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems.
The American journal of surgical pathology 2005;29(3):295-304.
2005: Esther Elishaev; C Blake Gilks; Dianne Miller; Monica Srodon; Robert J Kurman; Brigitte M Ronnett
Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
The American journal of surgical pathology 2005;29(3):281-94.
2005: C Blake Gilks; Barbara C Vanderhyden; Shirley Zhu; Matt van de Rijn; Teri A Longacre
Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.
Gynecologic oncology 2005;96(3):684-94.
2005: Jill E Kucab; Cathy Lee; Ching-Shih Chen; Jiuxiang Zhu; C Blake Gilks; Mary Cheang; David Huntsman; Erika Yorida; Joanne T Emerman; Michael Pollak; Sandra E Dunn
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours.
Breast cancer research : BCR 2005;7(5):R796-807.
2005: J E Stone; R Parker; C Blake Gilks; Eric J Stanbridge; Shu-Yuan Liao; Christina Aquino-Parsons
Intratumoral oxygenation of invasive squamous cell carcimoma of the vulva is not correlated with regional lymph node metastasis.
European journal of gynaecological oncology 2005;26(1):31-5.
2005: Cheng-Han Lee; Hui Xue; Margaret Sutcliffe; Peter W Gout; David Huntsman; Dianne M Miller; C Blake Gilks; Yu-Zhuo Wang
Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.
Gynecologic oncology 2005;96(1):48-55.
2004: Michelle M M Woo; Abdulmohsen Alkushi; Harold G Verhage; anthony magliocco; Peter C K Leung; C Blake Gilks; Nelly Auersperg
Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7958-64.
2004: Avedis Kazanjian; Deeann Wallis; N H C Au; Rupesh Nigam; Koen J T Venken; Philip T Cagle; Burton F Dickey; Hugo J Bellen; C Blake Gilks; H Leighton Grimes
Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.
Cancer research 2004;64(19):6874-82.
2004: Nikita Makretsov; David Huntsman; Torsten O Nielsen; Erika Yorida; Michael Peacock; Mary Cheang; Sandra E Dunn; Malcolm Hayes; Matt van de Rijn; Chris D Bajdik; C Blake Gilks
Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6143-51.
2004: N H C Au; A M Gown; Mary Cheang; David Huntsman; Erika Yorida; W Mark Elliott; Julia Flint; John English; C Blake Gilks; H Leighton Grimes
P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2004;12(3):240-7.
2004: N H C Au; Mary Cheang; David Huntsman; Erika Yorida; Andrew J Coldman; W Mark Elliott; D Gwyn Bebb; Julia Flint; John English; C Blake Gilks; H Leighton Grimes
Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
The Journal of pathology 2004;204(1):101-9.
2004: Torsten O Nielsen; Forrest D Hsu; Kristin Jensen; Mary Cheang; Gamze Karaca; Zhiyuan Hu; Tina Hernandez-Boussard; Chad A Livasy; Dave Cowan; Lynn Dressler; Lars A Akslen; Joseph Ragaz; Allen M Gown; C Blake Gilks; Matt van de Rijn; Charles M Perou
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5367-74.
2004: Brigitte M Ronnett; Andre A. Kajdacsy-Balla; C Blake Gilks; Maria J Merino; Elvio Silva; Bruce A Werness; Robert H Young
Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
Human pathology 2004;35(8):949-60.
2004: Aruna M Somasiri; Julie S Nielsen; Nikita Makretsov; Marcia L McCoy; Leah Prentice; C Blake Gilks; Stephen K Chia; Karen Gelmon; David B Kershaw; David Huntsman; Kelly M McNagny; Calvin D Roskelley
Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression.
Cancer research 2004;64(15):5068-73.
2004: Robin L Parker; Philip B Clement; David J Chercover; Thangaraja Sornarajah; C Blake Gilks
Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(3):265-72.
2004: C Blake Gilks
Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(3):200-5.
2004: Michelle M M Woo; C Blake Gilks; Harold G Verhage; Teri A Longacre; Peter C K Leung; Nelly Auersperg
Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts.
Gynecologic oncology 2004;93(2):315-9.
2004: Abdulmohsen Alkushi; Peter Lim; Andrew J Coldman; David Huntsman; Dianne Miller; C Blake Gilks
Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(2):129-37.
2004: Matt van de Rijn; C Blake Gilks
Applications of microarrays to histopathology.
Histopathology 2004;44(2):97-108.
2004: loretta doan; Susan D Porter; Zhijun Duan; Marcella M Flubacher; Diego Montoya; Philip Tsichlis; Marshall Horwitz; C Blake Gilks; H Leighton Grimes
Targeted transcriptional repression of Gfi1 by GFI1 and GFI1B in lymphoid cells.
Nucleic acids research 2004;32(8):2508-19.
2004: Torsten O Nielsen; Heather N Andrews; Mary Cheang; Jill E Kucab; Forrest D Hsu; Joseph Ragaz; C Blake Gilks; Nikita Makretsov; Chris D Bajdik; Christy Brookes; Leonard M Neckers; Valentina Evdokimova; David Huntsman; Sandra E Dunn
Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.
Cancer research 2004;64(1):286-91.
2003: Sabine C Linn; Robert B West; Jonathan R Pollack; Shirley Zhu; Tina Hernandez-Boussard; Torsten O Nielsen; Brian P Rubin; Rajiv M Patel; John R Goldblum; David Siegmund; David Botstein; Patrick O Brown; C Blake Gilks; Matt van de Rijn
Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.
The American journal of pathology 2003;163(6):2383-95.
2003: Nikita Makretsov; C Blake Gilks; Andrew J Coldman; Malcolm Hayes; David Huntsman
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.
Human pathology 2003;34(10):1001-8.
2003: Torsten O Nielsen; Forrest D Hsu; John X O'Connell; C Blake Gilks; Poul H B Sorensen; Sabine Linn; Robert B West; Chih Long Liu; David Botstein; Patrick O Brown; Matt van de Rijn
Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.
The American journal of pathology 2003;163(4):1449-56.
2003: Abdulmohsen Alkushi; Julie A Irving; F Hsu; Beverley Dupuis; Chih Long Liu; M Rijn; C Blake Gilks
Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.
Virchows Archiv : an international journal of pathology 2003;442(3):271-7.
2003: C Blake Gilks; Abdulmohsen Alkushi; Jenice J W Yue; Dominique Lanvin; Thomas G Ehlen; Dianne M Miller
Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2003;22(1):29-36.
2002: Forrest D Hsu; Torsten O Nielsen; Abdulmohsen Alkushi; Beverley Dupuis; David Huntsman; Chih Long Liu; Matt van de Rijn; C Blake Gilks
Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(12):1374-80.
2002: Chih Long Liu; Wijan Prapong; Yasodha Natkunam; Ash A Alizadeh; Kelli Montgomery; C Blake Gilks; Matt van de Rijn
Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.
The American journal of pathology 2002;161(5):1557-65.
2002: Julie A Irving; Beverley Dupuis; Lily Wang; C Blake Gilks
Cyclical expression of the DNA mismatch repair enzyme hMLH1 in normal endometrium.
Fertility and sterility 2002;78(1):195-6.
2002: Kenneth S Poon; C Blake Gilks; John S T Masterson
Metastatic Crohn's disease involving the genitalia.
The Journal of urology 2002;167(6):2541-2.
2002: Robin L Parker; David Huntsman; David W Lesack; James B Cupples; Dennis R Grant; Majid Akbari; C Blake Gilks
Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.
American journal of clinical pathology 2002;117(5):723-8.
2002: Abdulmohsen Al Kushi; Peter Lim; Christina Aquino-Parsons; C Blake Gilks
Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(4):365-71.
2002: A Al-Ghamdi; D Freedman; D Miller; Catherine F Poh; Miriam P Rosin; L Zhang; C Blake Gilks
Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases.
Gynecologic oncology 2002;84(1):94-101.
2001: A Alsheikh; Z Mohamedali; E Jones; J Masterson; C Blake Gilks
Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(4):267-72.
2000: Julie A Irving; D F McFarland; D S Stuart; C Blake Gilks
Mitotic arrest of endometrial epithelium after paclitaxel therapy for breast cancer.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2000;19(4):395-7.
2000: C Blake Gilks; Philip B Clement; W R Hart; R H Young
Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type: a clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief consideration of adenomyomas of other female genital tract sites.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2000;19(3):195-205.
1999: E T Wong; D E Jenne; M Zimmer; Susan D Porter; C Blake Gilks
Changes in chromatin organization at the neutrophil elastase locus associated with myeloid cell differentiation.
Blood 1999;94(11):3730-6.
1999: D Crawford; M Nimmo; Philip B Clement; TA Thomson; J L Benedet; D Miller; C Blake Gilks
Prognostic factors in Paget's disease of the vulva: a study of 21 cases.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1999;18(4):351-9.
1999: Joanne L Wright; Jin Dai; Katalin Zay; K Price; C Blake Gilks; Andrew Churg
Effects of cigarette smoke on nitric oxide synthase expression in the rat lung.
Laboratory investigation; a journal of technical methods and pathology 1999;79(8):975-83.
1999: Peter Lim; Christina Aquino-Parsons; F Wong; Beverley Dupuis; D Phillips; C Zhou; C Blake Gilks
Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.
Gynecologic oncology 1999;73(2):191-5.
1999: Susan D Porter; J Hu; C Blake Gilks
Distal upstream tyrosinase S/MAR-containing sequence has regulatory properties specific to subsets of melanocytes.
Developmental genetics 1999;25(1):40-8.
1998: Brett M Wehrli; Stan Krajewski; Randy D Gascoyne; J C Reed; C Blake Gilks
Immunohistochemical analysis of bcl-2, bax, mcl-1, and bcl-X expression in ovarian surface epithelial tumors.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1998;17(3):255-60.
1998: C Blake Gilks; K Price; J L Wright; A Churg
Antioxidant gene expression in rat lung after exposure to cigarette smoke.
The American journal of pathology 1998;152(1):269-78.
1998: C Zhou; C Blake Gilks; M Hayes; Philip B Clement
Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases.
The American journal of surgical pathology 1998;22(1):113-20.
1997: C Blake Gilks; Robert H Young; D J Gersell; Philip B Clement
Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases.
The American journal of surgical pathology 1997;21(8):905-14.
1997: G S Vogrincic; John X O'Connell; C Blake Gilks
Giant cell tumor of tendon sheath is a polyclonal cellular proliferation.
Human pathology 1997;28(7):815-9.
1996: H Leighton Grimes; C Blake Gilks; Tung O Chan; S Porter; Philip Tsichlis
The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(25):14569-73.
1996: C Thurley; Baljinder Salh; W Kwan; H Freeman; C Blake Gilks
Analysis of germline and expressed T cell receptor variable region genes in Crohn's disease.
Pathology, research and practice 1996;192(10):1022-30.
1996: D Lesack; I Wahab; C Blake Gilks
Radiation-induced atypia of endocervical epithelium: a histological, immunohistochemical and cytometric study.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1996;15(3):242-7.
1996: L H Argatoff; John X O'Connell; Joan A Mathers; C Blake Gilks; Poul H B Sorensen
Detection of the EWS/WT1 gene fusion by reverse transcriptase-polymerase chain reaction in the diagnosis of intra-abdominal desmoplastic small round cell tumor.
The American journal of surgical pathology 1996;20(4):406-12.
1995: William A Gourlay; V Chan; C Blake Gilks
Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1995;8(4):394-7.
1995: C Blake Gilks; Susan D Porter; C Barker; Philip Tsichlis; Peter W Gout
Prolactin (PRL)-dependent expression of a zinc finger protein-encoding gene, Gfi-1, in Nb2 lymphoma cells: constitutive expression in autonomous sublines.
Endocrinology 1995;136(4):1805-8.
1995: DW Bell; T Taguchi; Nancy A Jenkins; D J Gilbert; Neal G Copeland; C Blake Gilks; Patrick A Zweidler-McKay; H Leighton Grimes; Philip Tsichlis; Joseph R Testa
Chromosomal localization of a gene, GF1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents.
Cytogenetics and cell genetics 1995;70(3-4):263-7.
1994: W Donn; P Rebbeck; C Wilson; C Blake Gilks
Idiopathic granulomatous mastitis. A report of three cases and review of the literature.
Archives of pathology & laboratory medicine 1994;118(8):822-5.
1994: C A Thurley; W C Kwan; H J Freeman; C Blake Gilks
T cell receptor gene expression and genotypes in celiac disease.
Pathobiology : journal of immunopathology, molecular and cellular biology 1994;62(5-6):311-8.
1993: S Porter; C Blake Gilks
Genomic imprinting: a proposed explanation for the different behaviours of testicular and ovarian germ cell tumors.
Medical hypotheses 1993;41(1):37-41.
1993: C Blake Gilks; Susan E Bear; H Leighton Grimes; Philip Tsichlis
Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein.
Molecular and cellular biology 1993;13(3):1759-68.
1992: C Blake Gilks; P B Clement
Papillary serous adenocarcinoma of the uterine cervix: a report of three cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(4):426-31.
1992: C Blake Gilks; V C Ho; R D Gascoyne; D J Ellison
T-cell receptor variable region gene expression in cutaneous T-cell lymphomas.
Journal of cutaneous pathology 1992;19(1):21-6.
1991: C Blake Gilks; D J Ellison
Intratumoral T lymphocytes from small cleaved follicular center cell lymphomas show unrestricted T-cell receptor alpha-chain variable region gene usage.
The American journal of pathology 1991;139(1):25-8.
1990: C Blake Gilks; D A Bell; R E Scully
Serous psammocarcinoma of the ovary and peritoneum.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1990;9(2):110-21.
1989: C Blake Gilks; Robert H Young; P Aguirre; R A DeLellis; R E Scully
Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases.
The American journal of surgical pathology 1989;13(9):717-29.
1989: C D Becker; C Blake Gilks; H J Burhenne
Biological effects of biliary shock wave lithotripsy in swine.
Investigative radiology 1989;24(5):366-70.
1989: C Blake Gilks; B D Acker; Philip B Clement
Recurrent endometrial adenocarcinoma: presentation as a splenic mass mimicking malignant lymphoma.
Gynecologic oncology 1989;33(2):209-11.
1989: C Blake Gilks; P E Reid; Philip B Clement; D A Owen
Histochemical changes in cervical mucus-secreting epithelium during the normal menstrual cycle.
Fertility and sterility 1989;51(2):286-91.
1988: C Blake Gilks; P E Reid; P B Clement; D A Owen
Simple procedure for assessing relative quantities of neutral and acidic sugars in mucin glycoproteins: its use in assessing cyclical changes in cervical mucins.
Journal of clinical pathology 1988;41(9):1021-4.
1987: C Blake Gilks; G P Taylor; Philip B Clement
Inflammatory pseudotumor of the uterus.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1987;6(3):275-86.